Literature DB >> 1124697

Crystalline structure of heparin.

E D Atkins, I A Nieduszynski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1124697     DOI： 10.1007/978-1-4684-0946-8_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

2.  Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.

Authors:  D Lietha; D Y Chirgadze; B Mulloy; T L Blundell; E Gherardi
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  Structural specificity of heparin binding in the fibroblast growth factor family of proteins.

Authors:  Rahul Raman; Ganesh Venkataraman; Steffen Ernst; V Sasisekharan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

4.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

5.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

6.  Structural characterization of human heparanase reveals insights into substrate recognition.

Authors:  Liang Wu; Cristina M Viola; Andrzej M Brzozowski; Gideon J Davies
Journal:  Nat Struct Mol Biol       Date:  2015-11-16       Impact factor: 15.369
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.